Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 4
2007 4
2008 2
2009 1
2010 3
2011 5
2012 1
2013 2
2014 3
2016 1
2017 4
2018 4
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Huntingtin Expression in Patients with Huntington's Disease.
Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schobel SA, Paz E, Smith AV, Bennett CF, Lane RM; Phase 1–2a IONIS-HTTRx Study Site Teams. Tabrizi SJ, et al. N Engl J Med. 2019 Jun 13;380(24):2307-2316. doi: 10.1056/NEJMoa1900907. Epub 2019 May 6. N Engl J Med. 2019. PMID: 31059641 Clinical Trial.
Emerging Immunotherapies for Parkinson Disease.
Zella SMA, Metzdorf J, Ciftci E, Ostendorf F, Muhlack S, Gold R, Tönges L. Zella SMA, et al. Among authors: muhlack s. Neurol Ther. 2019 Jun;8(1):29-44. doi: 10.1007/s40120-018-0122-z. Epub 2018 Dec 11. Neurol Ther. 2019. PMID: 30539376 Free PMC article. Review.
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.
Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L. Zella MAS, et al. Among authors: muhlack s. Cells. 2019 Jan 31;8(2):105. doi: 10.3390/cells8020105. Cells. 2019. PMID: 30708997 Free PMC article. Review.
Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.
Pesch B, Casjens S, Woitalla D, Dharmadhikari S, Edmondson DA, Zella MAS, Lehnert M, Lotz A, Herrmann L, Muhlack S, Kraus P, Yeh CL, Glaubitz B, Schmidt-Wilcke T, Gold R, van Thriel C, Brüning T, Tönges L, Dydak U. Pesch B, et al. Among authors: muhlack s. Cells. 2019 Jan 29;8(2):96. doi: 10.3390/cells8020096. Cells. 2019. PMID: 30699914 Free PMC article.
Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients.
Richter D, Woitalla D, Muhlack S, Gold R, Tönges L, Krogias C. Richter D, et al. Among authors: muhlack s. Front Neurol. 2018 Aug 7;9:645. doi: 10.3389/fneur.2018.00645. eCollection 2018. Front Neurol. 2018. PMID: 30131761 Free PMC article.
Association of exposure to manganese and iron with relaxation rates R1 and R2*- magnetic resonance imaging results from the WELDOX II study.
Pesch B, Dydak U, Lotz A, Casjens S, Quetscher C, Lehnert M, Abramowski J, Stewig C, Yeh CL, Weiss T, van Thriel C, Herrmann L, Muhlack S, Woitalla D, Glaubitz B, Schmidt-Wilcke T, Brüning T. Pesch B, et al. Among authors: muhlack s. Neurotoxicology. 2018 Jan;64:68-77. doi: 10.1016/j.neuro.2017.08.008. Epub 2017 Aug 25. Neurotoxicology. 2018. PMID: 28847517 Free PMC article.
Association of exposure to manganese and iron with striatal and thalamic GABA and other neurometabolites - Neuroimaging results from the WELDOX II study.
Casjens S, Dydak U, Dharmadhikari S, Lotz A, Lehnert M, Quetscher C, Stewig C, Glaubitz B, Schmidt-Wilcke T, Edmondson D, Yeh CL, Weiss T, Thriel CV, Herrmann L, Muhlack S, Woitalla D, Aschner M, Brüning T, Pesch B. Casjens S, et al. Among authors: muhlack s. Neurotoxicology. 2018 Jan;64:60-67. doi: 10.1016/j.neuro.2017.08.004. Epub 2017 Aug 11. Neurotoxicology. 2018. PMID: 28803850 Free PMC article.
Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
Scherbaum R, Hartelt E, Kinkel M, Gold R, Muhlack S, Tönges L. Scherbaum R, et al. Among authors: muhlack s. J Neurol. 2020 Apr;267(4):954-965. doi: 10.1007/s00415-019-09657-7. Epub 2019 Dec 3. J Neurol. 2020. PMID: 31797086
Levodopa, placebo and rotigotine change biomarker levels for oxidative stress.
Muhlack S, Kinkel M, Herrman L, Müller T. Muhlack S, et al. Neurol Res. 2017 May;39(5):381-386. doi: 10.1080/01616412.2017.1295520. Epub 2017 Feb 22. Neurol Res. 2017. PMID: 28222651
39 results
Jump to page
Feedback